Predicting Survival Among Colorectal Cancer Patients: Development and Validation of Polygenic Survival Score
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study developed a polygenic survival scoring system (PSS) to predict colorectal cancer survival. The PSS accurately identifies patients with high mortality risk, aiding future research and treatment strategies.
Area Of Science
- Oncology
- Genomics
- Bioinformatics
Background
- Colorectal cancer is a leading cause of cancer mortality.
- Multi-omics approaches reveal cancer mutations and cellular responses.
- Identifying survival predictors is crucial for patient outcomes.
Purpose Of The Study
- To identify factors associated with colorectal cancer survival.
- To develop and validate a polygenic survival scoring system (PSS) using multi-omics data.
Main Methods
- Utilized The Cancer Genome Atlas (TCGA) data for colon (TCGA-COAD) and rectal (TCGA-READ) adenocarcinomas.
- Employed Cox proportional hazards regression to analyze demographic, clinical, and gene expression data.
- Developed and validated a PSS for colorectal cancer survival prediction.
Main Results
- Identified age, cancer stage, and nine gene expressions as predictors of colon cancer survival.
- The PSS demonstrated high accuracy in predicting colorectal cancer survival.
- Patients with low PSS scores had significantly higher 5-year survival rates.
Conclusions
- Integrated clinical and transcriptome data to identify key survival predictors.
- The PSS is a validated and accurate tool for estimating colorectal cancer survival.
- The PSS can significantly contribute to future colorectal cancer research and clinical applications.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Survival Times Are Positively Skewed
Survival times often exhibit positive skewness, unlike the normal distribution assumed...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...